in138In ongoing Phase 12 studies, MHB036C has been evaluated in 138 patients with advanced or metastatic solid tumors. The ADC has demonstratedinstruments, primarily depends upon the integrity and honesty of the parties involved. The objective of Section 138 of the Negotiable Instrument Act is to instil faith in